Hinge Health Raises 2Q, FY Guidance

Dow Jones
Jun 10

By Kelly Cloonan

 

Hinge Health boosted its guidance for the second quarter and full year, citing higher member conversion and performance across its client base.

The digital-health company said Tuesday it now expects revenue of $200 million to $202 million for the second quarter, compared with its prior forecast of $194 million to $196 million. The company now projects adjusted income from operations to be between $50 million and $52 million, compared with its prior guidance of $47 million to $49 million.

For the full year, Hinge Health now expects revenue between $818 million and $824 million, up from a previous range of $798 million to $804 million. It now expects adjusted income from operations of $217 million to $227 million for the year, compared with $205 million to $215 million previously.

"We're pleased with the continued momentum we're seeing in our business," Chief Financial Officer James Budge said. "The value we are delivering to our members, clients and partners is driving higher member conversion and performance across our client base."

The raised guidance comes ahead of the company's investor day, planned for Wednesday.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

June 09, 2026 16:31 ET (20:31 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10